Source:http://linkedlifedata.com/resource/pubmed/id/19120769
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2009-1-5
|
pubmed:abstractText |
Drug reaction can be one of the triggering factors either for exacerbation of pre-existing psoriasis or precipitation of psoriasis de novo. Herein, we report a case with psoriasiform drug eruption due to pravastatin, but it relapsed after discontinuance of the drug. Serial investigation of the histopathology and immunohistochemistry with anti-signal transducer and activator of transcription 3 (STAT3) revealed drug reaction-associated lesions intermingled with psoriasiform changes, which later predominated, suggesting a conversion into psoriasis de novo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0385-2407
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
732-6
|
pubmed:meshHeading |
pubmed-meshheading:19120769-Aged, 80 and over,
pubmed-meshheading:19120769-Drug Eruptions,
pubmed-meshheading:19120769-Female,
pubmed-meshheading:19120769-Humans,
pubmed-meshheading:19120769-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19120769-Pravastatin,
pubmed-meshheading:19120769-Psoriasis,
pubmed-meshheading:19120769-Skin
|
pubmed:year |
2008
|
pubmed:articleTitle |
Transition of psoriasiform drug eruption to psoriasis de novo evidenced by histopathology.
|
pubmed:affiliation |
Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan.
|
pubmed:publicationType |
Journal Article,
Case Reports
|